Rowena Yip
Overview
Explore the profile of Rowena Yip including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
1866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gros L, Yip R, Flores R, Zhang J, Paksashvili N, Zhang L, et al.
Lung Cancer
. 2025 Mar;
202:108465.
PMID: 40043632
Background: Increased lung cancer screening has made early-stage non-small-cell lung cancer (NSCLC) more common, with lung-sparing surgery as the standard curative treatment. Our study evaluated patients who underwent surgery for...
2.
Lancaster H, Walstra A, Myers K, Avila R, Gratama J, Heuvelmans M, et al.
Eur J Cancer
. 2025 Mar;
220:115323.
PMID: 40022837
Reduction in lung cancer mortality is achievable through low dose computed tomography (LDCT) screening in high-risk individuals. Many countries are progressing from local LDCT screening studies to national screening programs....
3.
Mulshine J, Pyenson B, Healton C, Aldige C, Avila R, Blum T, et al.
Eur J Cancer
. 2025 Feb;
218:115264.
PMID: 39904127
Large-scale lung cancer screening implementation combined with improvements in early detection techniques for three major tobacco-related diseases presents a rare opportunity to markedly improve population health outcomes for millions of...
4.
Gros L, Yip R, Golombeck A, Yankelevitz D, Henschke C
JTO Clin Res Rep
. 2025 Jan;
6(2):100777.
PMID: 39877030
Introduction: Limited information exists on next-generation sequencing (NGS) success for lung tumors of 30 mm or less. We aimed to compare NGS success rates across biopsy techniques for these tumors,...
5.
Sun Q, Li P, Zhang J, Yip R, Yankelevitz D, Henschke C
Radiology
. 2025 Jan;
314(1):e240599.
PMID: 39807982
Background Angiolymphatic invasion (ALI) is an important prognostic indicator in non-small cell lung cancer (NSCLC). However, few studies focus on radiologic features for predicting ALI in patients with early-stage NSCLCs...
6.
Yankelevitz D, Yip R, Jirapatnakul A, Henschke C
Eur J Cancer
. 2024 Dec;
216:115184.
PMID: 39705970
There have been enormous advances in the approach to assessing malignancy status of indeterminate pulmonary nodules including risk models, image based biomarkers and numerous types of biologic and molecular markers....
7.
Gros L, Yip R, Zhu Y, Li P, Paksashvili N, Sun Q, et al.
Sci Rep
. 2024 Dec;
14(1):29851.
PMID: 39617764
Lung cancer, the leading cause of cancer deaths globally, has better survival rates with early detection. Annual low-dose CT (LDCT) screenings are recommended for high-risk individuals due to age and...
8.
Yankelevitz D, Yip R, Henschke C
Radiology
. 2024 Oct;
313(1):e240420.
PMID: 39436291
Background Diagnostic workup of small pulmonary nodules often requires follow-up CT scans to confirm nodule growth before invasive diagnostics or treatment. Purpose To confirm prior results from the International Early...
9.
Assessing Bronchiectasis Progression in Low-dose Screening for Lung Cancer: Frequency and Predictors
Cai Q, Triphuridet N, Zhu Y, Yip R, Yankelevitz D, Metersky M, et al.
J Thorac Imaging
. 2024 Sep;
PMID: 39279296
Purpose: Bronchiectasis is associated with loss of lung function, substantial use of health care resources, and increased morbidity and mortality in people with cardiopulmonary diseases. We assessed the frequency of...
10.
Jirapatnakul A, Yip R, Myers K, Cai S, Henschke C, Yankelevitz D
Quant Imaging Med Surg
. 2024 Jul;
14(7):5057-5071.
PMID: 39022249
Background: Measurements are not exact, so that if a measurement is repeated, one would get a different value each time. The spread of these values is the measurement uncertainty. Understanding...